Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.
Journal: Frontiers in pharmacology
Published: April 25, 2026
Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe.
Journal: Pharmacogenomics
Published: December 09, 2025
A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report.
Journal: Cancer management and research
Published: October 08, 2025
Haematological, renal and hepatic toxicity profiles of infusional 5-fluorouracil versus capecitabine in African gastrointestinal cancer patients: a retrospective cohort study.
Journal: Ecancermedicalscience
Published: September 26, 2025
Trends in gastrointestinal cancer burden in Zimbabwe: 10-year retrospective study 2009-2018.
Journal: Ecancermedicalscience
Published: August 14, 2024
SPARKing academic technologies across the valley of death.
Journal: Nature biotechnology
Published: February 16, 2024
Identification of drug repurposing candidates for amyotrophic lateral sclerosis using electronic health records: a retrospective cohort study.
Journal: The Lancet. Digital health
Published: December 15, 2023
Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease.
Journal: Discover mental health
Published: October 19, 2023
An electronic health record cohort of Veterans with amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 09, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.
Journal: The Journal of investigative dermatology
Published: October 18, 2022
A US clinical trial network is needed for the next pandemic.
Journal: Nature medicine
Published: May 31, 2022
Azetidine-2-Carboxylic Acid-Induced Oligodendrogliopathy: Relevance to the Pathogenesis of Multiple Sclerosis.
Journal: Journal of neuropathology and experimental neurology
Published: May 06, 2022
Last Updated: 09/26/2026